Cronus Pharma Introduces Pimobendan Chewable Tablets (First FDA-Approved Generic) for Veterinary Use
Cronus Pharma LLC, a leader in animal health innovation, is excited to announce the release of its new Pimobendan Chewable Tablets, available for purchase in the U.S. veterinary market after June 9, 2026. This product is designed to support veterinarians in providing high-quality cardiac care for dogs. It is the first FDA-approved bioequivalent of Vetmedin®.
Cronus Pharma Launches Butorphic® (Butorphanol Tartrate) Sterile Injectable Solution
Cronus Pharma LLC, a fully integrated research, development, manufacturing, sales and marketing animal health pharmaceutical company, announces the launch of Butorphic® (Butorphanol Tartrate) Sterile Injectable Solution for immediate availability in the U.S. animal health market through national and regional distributors.
Cronus Pharma Hires Todd Brodersen as Senior Director of Sales & Marketing
Cronus Pharma LLC, a fully integrated research & development, manufacturing and marketing animal health pharmaceutical company, announced Mr. Todd Brodersen has joined as Senior Director of Sales & Marketing.
